Blog

Cellectis: The Next And Definitive Wave Of CAR-T – Seeking Alpha

Cellectis: The Next And Definitive Wave Of CART
Seeking Alpha
Despite recent dips related to early clinical experiences with allogeneic T-cells, Cellectis (CLLS) represents a particularly attractive buying opportunity at this time for the following three reasons: the fact that recent hiccups in preliminary data

2017-12-09 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.